EGFR and neoplasm: The finding of higher numbers of comutations in patients harboring EGFR amplification events could therefore be a possible effect of increased aggressiveness and higher tumor burden (with more extensive disease shedding more cfDNA and thus permitting detection of more alterations), or, alternatively, higher numbers of comutations could be a cause of increased aggressiveness.